... San Antonio Breast Cancer Symposium. December ... Celcuity is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health tablet ...
News
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ... - BioSpace
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
... biotechnology company advancing therapies that ... The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer ...
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.
- Holland & Knight Expands Intellectual Property Group with Addition of Partner Kenneth ...
His practice covers various industries, including biotech ... degree in physiology from The University of Texas Health Science Center at San Antonio and ...